panel: durable gmp compliance for cell and gene therapies
Published 3 years ago • 225 plays • Length 41:38Download video MP4
Download video MP3
Similar videos
-
53:56
panel: cell and gene therapies for ophthalmologic diseases
-
54:19
panel: cell and gene therapy for neurological product indications
-
50:13
panel: cell therapy manufacturing
-
58:25
panel: current realities of make vs. buy for cell & gene therapy manufacturing
-
59:49
plenary session: gene therapy & gene-modified cell therapies
-
1:05:49
panel: cell and gene therapies for chronic conditions
-
1:29
cmc challenges in cell and gene therapy manufacturing
-
1:11:29
panel: acceptance and uptake of cell and gene therapies: lessons learned and future focus
-
23:40
expediting the development of cell and gene therapy
-
1:21:38
overcoming challenges to gene therapy manufacturing workshop
-
52:32
panel: when does investing in cell and gene therapy make business sense?
-
49:16
panel: the state of investment in cell and gene therapy
-
44:30
panel: gene therapy manufacturing
-
38:41
panel: cell therapies: essential requirements for near-term and long-term commercial success
-
59:51
panel: what cell & gene therapy investors are looking for now
-
1:02:29
panel: safety and efficacy considerations for cell and gene therapies
-
1:01:18
digital innovation for cell and gene therapies redefining manufacturing through the digital protocol
-
17:07
sio gene therapies
-
46:39
what’s next for cell and gene therapies in 2023 and beyond